Abstract:Poststroke fatigue (PSF) is a multi-dimensional fatigue syndrome involving the complexity of the body, emotion, cognition, and society. [ 1 ] PSF is mostly manifested as pathological fatigue that cannot be alleviated after rest, and it persists. [ 2 ] PSF is a common complication in elderly patients with ischemic stroke (IS), and its incidence is between 42% and 53%. [ 3 ] PSF mostly begins in the acute-phase of stroke, and the acute-phase is a critical period for the functional recovery of patients. Studies have shown that the duration of PSF can reach more than 18 months, [ 4 ] and almost half of adults will complain of fatigue at any stage after stroke. [ 3 ] Long-term fatigue can reduce the rehabilitation compliance and quality of life of elderly patients with IS and even increase the risk of death. [ 5 , 6 ] The Stroke Priority Setting Partnership Steering Group in the UK pointed out that fatigue can seriously affect the quality of life even in people with complete physical recovery. Understanding and reducing fatigue during stroke rehabilitation and long-term care research are among the top 4 areas that medical staff should give priority to. [ 7 ] However, in clinical practice, fatigue is usually ignored by medical staff because its symptoms are not prominent. Therefore, conducting early risk assessment for PSF, identifying high-risk patients, promoting their early medical treatment, and transforming passive medical treatment into active health management are necessary.

Predictive value of serological indices for guiding bundle of care to prevent the occurrence of poststroke fatigue for ischemic stroke survivors